Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples